Case Series: Use of Dalbavancin for Invasive Gram-Positive Infection in Children.
With the limitations of this series and prior published data, dalbavancin may be a safe and efficacious antibiotic for use in certain invasive Gram-positive infections in children. It is a reasonable alternative when faced with relative contraindications to inpatient or outpatient parenteral therapy, especially when bactericidal therapy is needed or preferred. Formal pediatric trials against the standard of care, especially beyond skin/soft tissue infection, are encouraged.
Authors
- Shamim Islam (ORCID: https://orcid.org/0000-0002-6517-4875)
- Katherine Vermilye
- Patrick Kenney (ORCID: https://orcid.org/0000-0003-0410-5224)
- Mary Kathryn Mannix (ORCID: https://orcid.org/0000-0003-0661-2609)
- Oscar G. Gómez‐Duarte (ORCID: https://orcid.org/0000-0001-5628-5760)
- Andrea Green Hines
- Alice Sato
- Arthur J Chang
- Karl O A Yu
- Gitanjali L A Rebello
Institutions
- University of Southern California (US)
- Westchester Medical Center (US)
- Levine Children's Hospital (US)
- Children's Hospital & Medical Center (US)
- University of Nebraska Medical Center (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-02-01
- DOI
- https://doi.org/10.5863/jppt-24-00116
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00